Shah Capital has urged Novavax's board to pursue a sale of the biotech, citing a third consecutive year of poor rollout of ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at ...

If you have been tracking Novavax, you know it is the kind of stock that makes you wonder whether to hold on, cut losses, or set up for a comeback. Over the last month, the stock has climbed a sturdy ...

Himanshu Shah, managing partner and chief investment officer at Shah Capital, slammed management, and said the company should ...

Investing.com -- Novavax Inc (NASDAQ:NVAX) stock gained 2% Tuesday after Shah Capital, the company’s second-largest shareholder, sent a letter to the board urging an immediate strategic review for a ...

The federal guidance comes after many states have already announced their own Covid vaccine recommendations, creating ...

One of Novavax’s largest shareholders is again putting pressure on the Gaithersburg vaccine maker — this time, to consider a ...

The updated 2025-2026 COVID-19 vaccines are now widely available, but with some new limitations. Who can get the shot this ...

It's been a confusing and fast-changing couple of months for rules about getting a COVID shot. It should be a little easier ...

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is protein ...